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Abstract. Multiple Sclerosis (MS) is a chronic and potentially highly
disabling disease that can cause permanent damage and deterioration
of the central nervous system. In Europe it is the leading cause of non-
traumatic disabilities in young adults, since more than 700,000 EU peo-
ple suffer from MS. Although recent studies on MS pathophysiology have
been provided, MS remains a challenging disease. In this context, thanks
to recent advances in software and hardware technologies, computational
models and computer simulations are becoming appealing research tools
to support scientists in the study of such disease. Thus, motivated by
this consideration we propose in this paper a new model to study the
evolution of MS in silico, and the effects of the administration of Da-
clizumab drug, taking into account also spatiality and temporality of
the involved phenomena. Moreover, we show how the intrinsic symme-
tries of the system can be exploited to drastically reduce the complexity
of its analysis.
Keywords: Multiple sclerosis; Computational model; Colored Petri Nets
1 Introduction
Multiple Sclerosis (MS) is a long-term and autoimmune disease of
the Central Nervous System (CNS). During the progression of the
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disease, cells of immune system attack the principal components
of the CNS, the neurons, removing the enveloping myelin and pre-
venting the efficient transmission of the nervous signals. Relapsing-
Remitting MS (RRMS) is the predominant type of MS since it is
diagnosed in about 85% − 90% of MS cases [19]. In RRMS, the
disease alternates two phases: (1) relapse phase is characterized by
a disease worsening due to the active inflammation damaging the
neurons; (2) in the remission phase there is a complete or partial
lack of the symptoms [10]. Recently, many treatments were pro-
posed and studied to contrast the RRMS progression. Among these
drugs, daclizumab [5] (commercial name Zynbrita), an antibody tai-
lored against the Interleukin-2 receptor (IL2R) of T cells, exhibited
promising results. Unfortunately, its efficacy was accompanied by
an increased frequency of serious adverse events as infections, en-
cephalitis, and liver damages. For these reasons daclizumab has been
withdrawn from the market worldwide.
In [14] we proposed a model to investigate the effect of the da-
clizumab administration in RRMS. It involves the following seven
main actors of MS: Epstain-Barr virus (EBV), Effector T lympho-
cytes cells (Teff), Regulatory T lymphocytes cells (Treg), Natural
Killer cells (NK), Oligodentrocytes cells (ODC), Interleukin-2 (IL2)
and daclizumab (DAC). In details, the EBV was considered since
several studies [20] commonly agree with the hypothesis that viruses
may play a role in RRMS pathogenesis acting as environmental trig-
gers, and in particular the presence of this virus represents a well
established risk factor in MS [11]. Effector T cells (Teff) are instead
immune cells with a protective role against pathogens in healthy peo-
ple. However, in RRMS a hypothesis is that the EBV first infection
could bring to the activation of autologous Teff lymphocytes against
myelin, due to a structure similarity between one viral protein and
myelin protein (molecular mimicry). Regulatory T cells (Treg) are
immune cells acting as balancing of the immune response since they
contribute to suppress and modulate the Teff cells activity when no
longer needed, or when there is a high risk of inflammation that can
cause injuries to the tissues of the host. Another important actor
are the natural killer (NK) cells, a family of immune cells that acts
as host-rejection of infected cells. Oligodendrocytes (ODC) are in-
stead cells supporting the neurons since they produce and are able
to partially restore the myelin around the neurons if a not excessive
damage occurs. IL2 is an immunomodulatory cytokine released by
Teff in order to self-stimulate to duplicate and to propagate their im-
mune actions. Finally, we included in the model the drug daclizumab,
a humanized monoclonal antibody used in MS as drug against the
Interleukin-2 receptor (IL2R) that is able to break the autoimmune
reaction by suppressing the immune cells proliferation [5].
Thus, to help scientists in improving their knowledge of these
phenomena, in this work we extend the RRMS models presented in
[14] considering the cells movement into a three-dimensional grid.
In details, in this paper we show how the use of a graphical for-
malism, i.e. the Extended Stochastic Symmetric Net (ESSN) for-
malism [13, 14], allows us to easily deal with this complex three-
dimensional model whose direct definition in terms of ODE system
becomes clearly unfeasible even for a small three-dimensional grid.
Indeed, for instance considering three-dimensional grid with dimen-
sion 3 × 3 × 3 the ESSN model is a bipartite graph with only 38
nodes (i.e. 13 places and 25 transitions) and approximately 90 arcs;
while its underlying deterministic process is an ODE system with
433 equations.
Moreover, the high level of parametrization and flexibility provided
in the model through this graphical formalism enables us to study
different grid dimensions without changing the structure of the model.
Similarly, in the analysis phase the ESSN model provides a power-
ful methodology that automatically exploits the system symmetries
to reduce the complexity (in terms of number of equations) of the
underlying deterministic process. Indeed in [3] we proposed an al-
gorithm that directly derives a compact ODE system from a ESSN
model in a symbolic way, through algebraic manipulation of ESSN
annotations.
2 Scientific background
In this section we introduce the Petri Nets (PNs) formalism used
to describe our model. PNs and their extensions are effective for-
malisms to model biological systems thanks to their capability of
representing in a simple and clear manner the system features and
to provide efficient techniques to derive system qualitative and quan-
titative properties. In details, PNs are bipartite directed graphs with
two types of nodes called places and transitions. Places, graphically
represented as circles, correspond to the state variables of the sys-
tem, while transitions, graphically represented as boxes, correspond
to the events that can induce a state change. The arcs connecting
places to transitions and vice versa express the relations between
states and event occurrences. Places can contain tokens, drawn as
black dots. The state of a PN, namely marking, is defined by the
number of tokens in each place. The system evolution is provided
by the firing of an enabled transition, where a transition is enabled
if and only if each input place contains a number of tokens greater
than or equal to a given threshold defined by the cardinality of the
corresponding input arc. The firing of an enabled transition removes
a fixed number of tokens from its input places and adds a fixed num-
ber of tokens into its output places (according to the cardinality of
its input/output arcs).
In this work we focus on Stochastic Symmetric Nets (SSNs) a
high level formalism that extends PNs with colors and stochastic
firing delays [8]. Colors provide a more compact, readable and para-
metric representation of the system thanks to the possibility of hav-
ing distinguished tokens.
More specifically, the color domain associated with a place spec-
ifies the color of the tokens contained in this place, whereas the color
domain of a transition defines the different ways of firing it (i.e. the
possible transition instances). In order to specify these firings, a color
function is attached to each arc which, given a color of the transition
connected to the arc, determines the number of colored tokens that
will be added to or removed from the corresponding place. A color
domain is defined as Cartesian product of color classes which may
be viewed as primitive domains. A color class can be partitioned into
static subclasses. The colors of a class have the same nature (e.g. T
cells), whereas the colors inside a static subclass have the same po-
tential behavior (e.g. Teff). Stochastic firing delays, sampled from
a negative exponential distribution, allow to automatically derive
the underlying Continuous Time Markov Chain (CTMC) that can
be studied to quantitatively evaluate the system behaviour. In the
literature, different techniques are proposed to solve the underlying
CTMC; in particular, in case of very complex models, the so-called
deterministic approach [12] can be efficiently exploited. According
to this, in [4] we proposed how to derive a deterministic process, de-
scribed through a system of Ordinary Differential Equations (ODEs),
which well approximates the stochastic behavior of an SSN model
assuming all reactions follow the Mass Action (MA) law. In the same
paper we also described an efficient translation method based on the
SSN formalism, which is able to reduce the size (in terms of equa-
tions number) of the underlying ODE system through the automatic
exploitation of system symmetries. Practically, the complete set of
ODEs, which can be derived from an SSN model is partitioned into
equivalence classes of ODEs which have same solution so that a rep-
resentative equation, called symbolic equation, can be pointed out
for each equivalence class. Then, a reduced ODE system may be de-
rived including only these symbolic equations whose solution mimics
the behavior of the original model. Recently this result was further
improved in [3] where a new algorithm is discussed to generate the
symbolic equation for each equivalence class of ODEs without deriv-
ing the complete ODE system. This is achieved thanks to a recent
extension of a symbolic calculus for the computation of SSN struc-
tural properties [7].
Furthermore, in [14] we introduced the Extended SSNs (ESSNs) to
deal with more complex biological laws splitting the set T of all the
transitions into two subsets: Tma and Tg. Thus, the former subset
contains transitions (that are called standard) whose rates are speci-
fied as MA laws. The latter includes instead all the transitions (that
are called general) whose random firing times have rates that are de-
fined as general real functions. In our definition, we assumed that the
general function associated with a transition t ∈ Tg is a real function
which depends only on time and on the input places of t. So, if xp,c(ν)
represents the average number of tokens of color c in the place p at
time ν, then the rate at which the instance 〈t, c, c′〉, t ∈ Tg will move
tokens with color c in place xp,c′(ν) is given by f〈t,c,c′〉(xˆ(ν), ν), where
xˆ(ν) is the vector characterized by the average number of tokens of
the input places of transition t.
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Fig. 1: a) Representation of the three-dimensional model. Each cube
contains the 7 elements characterizing the MS disease. Elements po-
sition is identified by three coordinates in the 3D cubic grid, repre-
senting a piece of CNS b) The ESSN model.
3 Materials and Methods
In this section, we report our extension of the Relapsing-Remitting
Multiple Sclerosis (RRMS) model presented in [14] considering the
cell movements in a cubic grid. The model, shown in Fig. 1b), con-
sists of 13 places and 25 transitions. For the sake of clarity, the white
transitions are standard ones, while the black ones are general tran-
sitions. All the general functions, the constants and numerical values
associated with the transitions, except for those regarding the move-
ment transitions, are reported in the [14]’s Supplementary file.This
model is organized in seven modules corresponding to the biological
entities characterizing RRMS. Briefly, the EBV module simulates
the virus injections in the system, while the Treg and Teff modules
encode the activation of the T cells, the annihilation of the virus by
the Teff action, the control mechanism of the Treg over the Teff. The
NK module describes the killing of self-reactive Teff and Treg cells
respectively, due to NK cells. The IL2 module is focused on the IL2
role. IL2 is consumed by the Treg, Teff and NK functions and it is
produced by the Teff activation. The ODC module describes instead
the ODC behaviour, characterized particularly by the damage caused
by Teff cells on ODC cells. Indeed, when the myelin level reaches the
lowest value, an irreversible damage occurs and a remyelination of
the neurons is no more possible.
Finally, the DAC module encodes the drug administration and
its pharmacokinetics inhibition of the expansion of Treg and Teff.
The model is characterized by four color classes: PosX, PosY,
and PosZ representing the coordinates of the position of a molecule
in a 3D cubic grid; Mye encoding the myelination levels of ODC.
Mye is divided into five static subclasses ranging from Lmin (no
myelination) to Lmax (full myelination). Then, all the places except
the ODC and EffectorMemory are characterized by the color domain
defined as Pos3D = PosX×PosY×PosZ, i.e. the three-dimensional
Cartesian product of the three coordinates color classes. Instead,
the ODC place is characterized by the three coordinates plus the
myelination levels, so that its color domain is Pos3D×Mye. Finally,
the EffectorMemory place has neutral color domain.
Moreover, we assume that the EBV, Teff, Treg and DAC cells
are able to move in all the cubic cells of the grid. Practically, the
EBVs move uniformly in all the cells, the Teff cells move with higher
probability towards a location in which there is higher concentra-
tion of EBV, and Treg and DAC cells move with higher probability
towards a location in which there is higher concentration of Teff
cells. Hereafter, the notation of the color combinations 〈px, py, pz〉
and 〈qx, qy, qz〉, representing the location coordinates, is simplified
to 〈p〉 and 〈q〉, respectively. In particular, we define xCellType〈p〉 as
the number of CellType in the location 〈p〉 at a specific time point.
Hence, the movement functions are defined as follows:
TeffMovement simulates the Teff movements from the coordi-
nates represented by the color combination 〈p〉 to 〈q〉. Its velocity
is inversely proportional to the number of EBV in 〈p〉 and depends
on the number of EBV in 〈q〉 such that a greater number of EBV
cells leads to a higher probability to move into that location.
f〈TeffMovement,p,q〉(xˆ(ν), ν) =rmoves ∗ (exp(−
xEBV〈p〉
CEBV
)) ∗ pTeff〈q〉 ∗ xTeff〈p〉
where pTeff〈q〉 =
xEBV〈q〉
EBVtot
represents the probability to move in the cell
with coordinates 〈q〉 and EBVtot is the total number of EBV in the
grid at time ν. Moreover, in our experiment we fixed rmoves = 0.1
and CEBV = 1000.
TregMovement represents the Treg movements from the coordi-
nates represented by the color combination 〈p〉 to the coordinates
〈q〉. This is inversely proportional to the number of Teff in 〈p〉 and
depends on the number of Teff in 〈q〉, such that a greater number
of Teffs leads to a higher probability to reach that location.
f〈TregMovement,p,q〉(xˆ(ν), ν) =rmoves ∗ (exp(−
xTeff〈p〉
CTeff
)) ∗ pTreg〈q〉 ∗ xTreg〈p〉
where pTreg〈q〉 =
xTeff〈q〉
Tefftot
represents the probability to move in the cell
with coordinates 〈q〉 and Teff tot is the total number of Teff in the
grid at time ν. Moreover, in our experiment we fixed rmoves = 0.1
and CTeff = 800.
EBVMovement simulates the EBV movements from the coordi-
nates represented by the color combination 〈p〉 to the coordinates
〈q〉. In this case we assume that the probability to move is equally
distributed among the grid cells.
f〈EBVMovement,p,q〉(xˆ(ν), ν) = rmoves ∗ pEBV〈q〉 ∗ xEBV〈p〉
where pEBV〈q〉 = 1/Ngrid represents the probability to move in the
cell with coordinates 〈q〉 with Ngrid being the number of cells in the
grid. Moreover, in our experiment we fixed rmoves = 0.1.
DACMovement simulates the DAC movements from the coor-
dinates represented by the color combination 〈p〉 to the coordi-
nates 〈q〉. This is inversely proportional to the number of T-cells
(Treg+Teff) in 〈p〉 and directly proportional to the number of T-
cells in 〈q〉.
f〈DACMovement,p,q〉(xˆ(ν), ν) =rmoves ∗ (exp(−
xTcells〈p〉
CTcell
)) ∗ pDAC〈q〉 ∗ xDAC〈p〉
where pDAC〈q〉 =
xTcells〈q〉
Tcellstot
represents the probability to move in
the cell with coordinates 〈q〉. Moreover, in our experiment we fixed
rmoves = 0.1 and CTcell = 1000.
All the R files, general transitions definition, data generated and
analyzed during this study, and the GreatSPN file of the net are
freely available at https://github.com/qBioTurin/ESSNandRRMS/
tree/master/DeterministicModel/Multidimensional.
The system of SODE has been generated with the SNespression tool
(http://di.unito.it/$\sim$depierro/SNexpression) and inte-
grated with the definition of the functions for the general transitions
and the initial marking.
4 Results
In this work we studied the RRMS considering a tissue portion ex-
plicitly modeled through a cubic grid composed by 27 cubic cells
(Fig. 1a) ). To achieve this, we defined the color classes PosX =
{x1 , x2 , x3}, PosY = {y1 , y2 , y3} and PosZ = {z1 , z2 , z3}. For all
the simulations, we assumed 500 ODC with level Lmax of neuronal
myelinization, 1687 resting Teff cells, 63 resting Treg cells, 375 NK
cells and 1000 IL2 molecules, and zero cells in the other places (for
more details see [14]).
We exploited the GreatSPN tool to draw the ESSN model (Fig. 1b).
This model is characterized by a system of 433 ODEs, but with few
assumptions it is possible to derive the corresponding reduced ODEs
system including only the symbolic equations. In details, let us define
the set of all the 27 location coordinates as P = {〈px, py, pz〉, px ∈
PosX , py ∈ PosY , pz ∈ PosZ}. Then, we consider three disjoint sub-
sets of P, namely P1, P2, P3; the first two represent the two sets
grouping the EBV and DAC injection locations, respectively, and
P3 the remaining locations. For simplicity and also to maintain the
symmetries into the system, the EBV and DAC injection locations
do not change over the simulation time and do not overlap. Given
this, it is possible to derive the symbolic ODEs (SODEs) system
characterized by 49 equations instead of 433. A further reduction is
represented by the number of terms in each SODE, representative of
an equivalence class of ODEs, with respect to the number of terms
appearing in the ODEs in the equivalence class, due to the factoriza-
tion obtained thanks to the presence of symmetries. Other examples
are reported in Table 1, where the R file dimension and the num-
ber of differential equations of the complete and reduced model are
compared considering different cubic grid dimension, from 3× 3× 3
to 5× 5× 5. It is easy to see that an increasing number of locations
is associated with an increase in the number of ODEs and of the R
file containing them, while the SODE system does not change. Note
that when the 5 × 5 × 5 grid is considered, the ODEs generation
procedure fails because it exceeds the available memory.
The advantage can also be observed from the viewpoint of the simu-
lation time, we obtained a speed up from 8.927205 hours to 12.76043
secs on an Intel Xeon processor @ 2GHz. Note that the simulation
was performed considering 3×3×3 cubic grid, one year interval and
assuming EBV injections at regular times (every two months), and
each injection introduces into the system 10000 EBV copies.
Number of locations R File dimension ODEs / SODEs Number of ODEs / SODEs
27 (3x3x3) 0.43 MiB / 0.023 MiB 433 / 49
64 (4x4x4) 5.0 MiB / 0.023 MiB 1025 / 49
125 (5x5x5) Out of memory / 0.023 MiB 2001 / 49
Table 1: Comparing the ODE and SODE system, varying the cubic
grid dimension.
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Fig. 2: Percentages of ODCs irreversibly damaged a) without and b)
with DAC treatment.
A possible evolution of the system is shown in Fig. 2, where the
red circles represent the location in which EBV is injected. For each
plot, the three rows represent the z-planes and the columns refer to
the time points in which the injections are done. Fixing the time
point and the z-plane, the corresponding 3 × 3 square reports the
number of ODCs damaged into the nine grid cells obtained varying
the x and y coordinates. As expected, the panel A of Fig. 2 shows
the progressive accumulation of ODC irreversibly damaged until day
365. Otherwise, in panel B of Fig. 2 is reported the results of the sim-
ulation of the DAC effect. In details, every month after two months
of simulation, two injections are simulated (green squares) intro-
ducing 300 DAC copies for each administration. These results agree
with those proposed in [14] since the number of irreversibly damaged
ODCs decreases in the case with DAC administration with respect
to the case in which no drug is injected. With DAC the percentage
of irreversibly damaged ODCs ranges from 19% to 24%, while with
no DAC the number of irreversibly damaged ODCs is between 70%
and 85%.
5 Conclusion
In this work we extended the model presented in [14] including the
spatial coordinates of all entities in a cubic tissue portion. This gives
the opportunity to model more realistic scenarios, where different
quantities of virus enter into the system from different directions.
Moreover, we described how the intrinsic symmetries of the de-
rived ESSN model may be automatically exploited to reduce the
complexity of the analysis step. This allows us to study models which
are independent from the grid size, while with the classical approach
it is hard to generate the ODEs system corresponding to the model
with a 5× 5× 5 grid.
As further work, we will focus our experiments on the dosage of DAC
and on the simulation of the DAC pharmacokinetics in order to sim-
ulate the up taking of DAC by the body, its biotransformation and
the distribution of DAC and its metabolites in the tissues.
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1 Appendix
In this Appendix we conclude the description of the model intro-
duced in the main paper Multiple Sclerosis disease: a computational
approach for investigating its drug interactions., an extension of the
Relapsing Remitting Multiple Sclerosis (RRMS) model presented in
[14] considering the cells movement into a three-dimensional grid. In
details, we report the function associated to the general transitions
of the model and all the constants value exploited during the exper-
iments. Let us note that in the next section we extend the functions
already introduced in [14], except the ones characterizing the move-
ments, in order to consider the new color instances regarding the
positions, which were not present in the previous work [14].
1.1 General transitions
In this section we recall that transitions which represent i) the killing
of a cell, e.g., TregKillsTeff or TeffKillsODC, ii) the entry of cells
into the system, such as EBVinj, iii) the activation of T cells, e.g.,
TeffActivation, iv) the duplication of a cell, e.g., such as TregDup,
and v) the cell movements e.g., TregMovements, are all modelled as
general transitions because they do not follow the Mass Action (MA)
law.
Let us recall the following notations:
– f〈t,c〉(xˆ(ν), ν) is the speed of the transition t ∈ Tg and xˆ(ν) rep-
resents the vector of the average numbers of tokens for all the
input places. For brevity, when the function will not depend on
the color instance c, we will omit the c and we will simplify the
specification of the function in the following way ft(xˆ(ν), ν).
– exp(− y
Cost
) represents a coefficient varying in [0, 1] and it is
directly related to the y value. This is usually multiplied to a
constant rate, so that an increase y involves a decrease in the
rate associated.
– xtot〈px,py,pz〉(ν) is the total number of cells in the grid cell with
coordinates 〈px, py, pz〉 at time ν. For simplicity, we will neglect
all the dependencies from the position 〈px, py, pz〉 and time ν, so
in the case of xtot〈px,py,pz〉(ν), it will be xtot. In general the notation
will be xName〈px,py,pz〉(ν) = xName.
All the general transitions of the model are now explained in details
and all the constants are summarized in Tables 2 and 1.
– EBVinj and DACinj inject into the system specific quantities of
EBV and DAC respectively at fixed time points;
– FromTimoREG, FromTimoEFF, and NKentry are the transi-
tions which keep in a constant range the number of RestingTreg,
RestingTeff , and NK respectively. They are defined as
f〈FromTimoREG,px,py ,pz〉(xResTreg, ν) = qRestTreg ∗ (1− xResTreg/63);
f〈FromTimoEFF,px,py ,pz〉(xResTeff , ν) = qRestTeff ∗ (1− xResTeff/1687);
f〈NKentry,px,py ,pz〉(xNK , ν) = qNK ∗ (1− xNK/375),
where xResTreg, xResTeff , and xNK are the numbers of cells in
the input places (i.e. RestingTreg for FromTimoREG, etc) at
time ν and position 〈px, py, pz〉. Then q− represents the quantity
injected in the output place to preserve the cell quantity, i.e. 63
for the RestingTreg, 1687 for the RestingTeff and 375 for the
NK.
– TregActivation and TeffActivation transitions model the activa-
tion of the Teff and Tref cells. In particular, these are specified as
general transitions to simulate a reduced Teff activation velocity
with respect to a decreasing virus presence, and a Treg activa-
tion velocity proportional to the number of Teffs and inversely
proportional to the number of EBV particles (allowing the Teff
to annihilate the virus). So the functions are defined as
f〈TregActivation,px,py ,pz〉(xˆ(ν), ν) = rTregA ∗
xTeff
(xTeff + xEBV + 1)
∗ xResTreg;
f〈TeffActivation,px,py ,pz〉(xˆ(ν), ν) = rTeffA ∗ (1− exp(−
xEBV
CEBV
)) ∗ xResTeff ,
where rTregA and rTeffA are the activation constant rates for the
Treg and Teff respectively. xˆ(ν), in case of the TregActivation
transition, consists of the variables xResTreg, xEBV , xTeff respec-
tively to the RestingTeff, EBV and Teff places, differently
the TeffActivation transition is characterized by xResTeff and
xEBV . Finally the constant CEBV is related to the EBV particles
and it is defined to reduce the activation rate with the decreasing
of the virus presence.
– MemActivation is defined as
f〈MemActivation,px,py ,pz〉(xˆ(ν), ν) =
{
0 ν < t2inj,
rMemA ∗ xMem(ν) ν ≥ t2inj,
where
rMemA = 2 ∗ rTeffA ∗ (1− exp(−xMem(ν)
CMem
) ∗ (1− exp(− xEBV
CEBV
),
and t2inj is the time corresponding to the second EBV injec-
tion. We considere this velocity as zero since the T Memory
effectors start to react after the first virus occurrence. xˆ(ν) =
(xMem(ν), xEBV (ν)) is the marking vector storing the number of
T Memory effectors (no position dependency) and EBV particles
in the place 〈px, py, pz〉, respectively at time ν. While CMem and
CEBV constant related to the Memory and EBV cells needed to
slow down the activation rate with the decreasing of EBV and
Memory cells. This because we have to leave a minimum number
of T Memory effectors into the system. So when in the system
there are large number of EBV particles and of T Memory effec-
tors, the activation speed reaches its maximum that is given by
twice the velocity of the Teff cells, rTeffA.
– All the transitions that model the killing of a specific cell are
defined as follow:
∀t ∈ {TregKillsTeff,TeffKillsODC,TeffKillsEBV,NKKillsTcell}
then
f〈t,px,py ,pz〉(xˆ(ν), ν) =
1
xtot
∗ rt ∗
∏
i
xˆi(ν),
where
∏
i xˆi(ν) is the product of the average numbers of tokens in
the input places of the transition t, rt is the constant rate related
to the transition t , and
1
xtot
represents the probability that a
specific meeting between two different cells occurs in the specific
grid cell.
– TregDup transition models the Treg duplication depending pro-
portionally on the amount of IL2 and inversely proportional on
the number of DAC cells (to simulate the reduced duplication
velocity during the Daclizumab therapy), and it is defined as
f〈TregDup,px,py ,pz〉(xˆ(ν), ν) = ηTrD(xˆ(ν), ν) ∗ xTreg ∗ xIL2 ∗
1
xtot
,
with
ηTrD(xˆ(ν), ν) = rTregDup ∗ (1− exp(− xIL2
CIL2
)) ∗ (exp(− xDAC
CDAC
)).
where rTregDup is the constant Treg duplication rate, xˆ(ν) ={
xTreg, xIL2, xDAC
}
and CIL2 and CDAC are the constants re-
lated to the IL2 and DAC cells to slow down the duplication
velocity with an increasing number of DACs and a decreasing
number of IL2 proteins.
– Considering the Teff duplication event we have to distinguish two
possible cases: 1) the Teff symmetric duplication with probability
pdupeff and a Teff asymmetric duplication, implying the T Memory
effector differentiation, with probability pmemeff = 1 − pdupeff . This
is modeled exploiting two different transitions: TeffDup Sym and
TeffDup Asym. So let us define
reffdup = ηTeD(xˆ(ν), ν) ∗ xTeff ∗ xIL2 ∗
1
xtot
then these two transitions are defined as:
f〈TeffDup Sym〉,px,py ,pz(xˆ(ν), ν) = p
dup
eff ∗ reffdup
and
f〈TeffDup Asym,px,py ,pz〉(xˆ(ν), ν) = p
mem
eff ∗ reffdup ,
with
ηTeD(xˆ(ν), ν) = rTeffDup ∗ (1− exp(− xIL2
CIL2
)) ∗ (exp(− xDAC
CDAC
)).
Where rTeffDup is the constant Teff duplication rate, xˆ(ν) ={
xTeff , xIL2, xDAC
}
.
For clarity, the notation for the movements functions of the color
combinations 〈px, py, pz〉 and 〈qx, qy, qz〉, representing the location
coordinates, is simplified to 〈p〉 and 〈q〉, respectively.
– TeffMovement simulates the movement of Teff cells from point
(with coordinates represented by the color combination) 〈p〉 to
point 〈q〉. The speed of this movement (the rate of transition
TeffMovement) is inversely related to the number of EBV cells in
〈p〉 and depends on the number of EBV in 〈q〉 such that a greater
number of EBV cells leads to a higher probability to move into
that location. This is captured by the following formula
f〈TeffMovement,p,q〉(xˆ(ν), ν) =rmoves ∗ (exp(−
xEBV〈p〉
CEBV
)) ∗ pTeff〈q〉 ∗ xTeff〈p〉
where rmoves is an experimental coefficient that we set equal to
0.1;
exp(−xEBV〈p〉
CEBV
) is a term that accounts for the fact that the ve-
locity of the movement is inversely related to the number of EBV
cells in the starting point going to 0 in a manner that is slower
than 1/xEBV〈p〉 ;
pTeff〈q〉 =
xEBV〈q〉
EBVtot
represents the probability to move in the cell with
coordinates 〈q〉 where EBVtot is the total number of EBV in the
grid at time ν; and CEBV is an experimental constant that we
set equal to 1000. All these quantities are functions of the time
ν which is omitted in the formula to keep the notation simpler.
– TregMovement represents the movements of the Treg cells from
point 〈p〉 to point 〈q〉. Similarly to what explained for transition
TeffMovement the speed is inversely related to the number of Teff
cells in 〈p〉 (term exp(−xTeff〈p〉
CTeff
) ) and depends on the number of
Teffs in 〈q〉 (term pTreg〈q〉 =
xTeff〈q〉
Tefftot
), such that a greater number
of Teffs leads to a higher probability to reach that location.
f〈TregMovement,p,q〉(xˆ(ν), ν) =rmoves ∗ (exp(−
xTeff〈p〉
CTeff
)) ∗ pTreg〈q〉 ∗ xTreg〈p〉
Again, in our experiment we fixed rmoves = 0.1 and CTeff = 800.
– EBVMovement simulates the EBV movements from point 〈p〉
to point 〈q〉. In this case we assume that the probability to move
is equally distributed among all the grid cells.
f〈EBVMovement,p,q〉(xˆ(ν), ν) = rmoves ∗ pEBV〈q〉 ∗ xEBV〈p〉
Also in this case, in our experiment we fixed rmoves = 0.1.
– DACMovement simulates the DAC movements from point 〈p〉
to point 〈q〉. This is inversely related to the number of T-cells
(Treg+Teff) in 〈p〉 as for the TeffMovement and TregMovement
cases and directly proportional to the number of T-cells in 〈q〉.
f〈DACMovement,p,q〉(xˆ(ν), ν) =rmoves ∗ (exp(−
xTcells〈p〉
CTcell
)) ∗ pDAC〈q〉 ∗ xDAC〈p〉
The quantities rmoves = 0.1 and CTcell = 1000 were used in this
last case.
1.2 Parameters
Table 1: List of the model fixed parameters with their corresponding
values for both the scenarios: healthy and Multiple Sclerosis (MS)
patient.
Transitions/events Parameters Healthy patient MS patient
Treg Death rTregD 1/24 h
−1 1/24 h−1
Teff Death rTeffD 1/24 h
−1 1/24 h−1
NK Death rNKD 1/24 h
−1 1/24 h−1
NK Dup rNKDup 1/24 h
−1 1/24 h−1
Teff Activation rTeffA 0.4 h
−1 0.4 h−1
Treg Activation rTregA 0.2 h
−1 0.2 h−1
Treg Dup rTregDup 0.09 h
−1 0.09 h−1
Teff Dup rTeffDup 0.5 h
−1 0.5 h−1
TeffKillODC rTeKodc 0.1 h
−1 0.15 h−1
TregKillTeff rTrKTe 3 h
−1 1 h−1
TeffKillEBV rTeKebv 0.15 h
−1 0.1 h−1
Recovery rrec 0.1 h
−1 0.1 h−1
NKKillTcell rNKkTc 0.1 h
−1 0.1 h−1
DACDeath rDacD − 1/(3 ∗ 30 ∗ 24) h−1
Table 2: List of the model constants.
Constant Value
qRestTreg 20
qRestTeff 500
qNK 100
CEBV 1000
CMem 200
CDAC 20
CIL2 200
CTcell 200
CTeff 200
pdupeff 2/3
pmemeff 1/3
Table 3: List of the cell numbers used in the model.
Cell Value Reference
TLymphocytes [3 ∗ 103cells/mm3] [1, 21]
RestingTeff [1687cells/mm3] [6, 9, 15,16]
RestingTreg [63cells/mm3] [18]
NK [375cells/mm3] [6, 9, 15,16]
ODC [125cells/mm3] [17]
EBV infection [50 − 70days] [2]
